Use cases
Built for clinical impact
and scalable distribution.
Stroke care
Strengthen stroke origin assessments
Improve stroke care with patient-specific stagnation data when a cardioembolic origin is suspected — identify the silent high-risk patient.
Ablation therapy
Transforming atrial fibrillation ablation
Move beyond ablation for symptomatic AF patients and optimise resources — prioritise ablation for stroke risk reduction.
Anticoagulant decision
Decision support for treatment
Informed anticoagulation strategy and decisions with a new precision marker that complements existing clinical risk scores.
Cordicity
More than improved imaging.
Talk to the team building the next quantitative marker in stroke care — whether you are a clinician, a partner, an investor or a future colleague.